Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Select a Mutual Fund
Risk | Very High | - |
Rating | - | - |
Min SIP Amount | ₹100 | - |
Expense Ratio | 0.94 | - |
NAV | ₹10.40 | - |
Fund Started | 02 Jun 2025 | - |
Fund Size | ₹12.93 Cr | - |
Exit Load | - | - |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | - | - |
3 Year | - | - |
5 Year | - | - |
1 Year
3 Year
5 Year
Equity | 99.32% | - |
Cash | 0.68% | - |
Equity
Cash
Top 10 Holdings |
| - |
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 17.67% |
Cipla Ltd. | 8.89% |
Max Healthcare Institute Ltd. | 8.71% |
Apollo Hospitals Enterprise Ltd. | 7.87% |
Dr. Reddy's Laboratories Ltd. | 7.84% |
Divi's Laboratories Ltd. | 7.60% |
Fortis Healthcare Ltd. | 5.31% |
Lupin Ltd. | 4.86% |
Torrent Pharmaceuticals Ltd. | 3.96% |
Laurus Labs Ltd. | 3.44% |
Name | Anil Ghelani | - |
Start Date | 08 Aug 2025 | - |
Name
Start Date
Description | The scheme seeks to generate returns that are commensurate with the performance of the Nifty Healthcare Index, subject to tracking error. | - |
Launch Date | 02 Jun 2025 | - |
Description
Launch Date